Skip to content

Endohead 01.25.240M

by Medacta International SA

Endohead 01.25.240M is a Class II device made by Medacta International SA, cleared under FDA 510(k) K111145 on 16 Aug 2011 and listed in FDA GUDID since 18 Nov 2014 (UDI-DI 07630030806216), active as of 12 Nov 2026.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 12 Nov 2026

Documents

510(k) K111145

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 12 Nov 2026.

Regulatory status

as of registry sync 12 Nov 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number07630030806216 UDI-DI Date18 Nov 2014ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE from GUDID Substantially Equivalent · Traditional NumberK111145 Date16 Aug 2011DecidedStatusActive

Official records

Across registries

2 registries list this device

  • FDA 510(k) K111145 decided 16 Aug 2011 Active
  • FDA GUDID UDI-DI 07630030806216 listed 18 Nov 2014 Listed

Timeline

2 dated events

  1. Cleared FDA 510(k) K111145
  2. Listed FDA GUDID 07630030806216

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
Endohead
Generic name
Bipolar femoral head outer component, hemiarthroplasty
Model / reference
01.25.240M
Primary DI / UDI-DI
07630030806216
510(k) Number
FDA product code
LZY
GMDN term
Bipolar femoral head outer component, hemiarthroplasty
Device class
Class II
Regulation number
888.3360
GUDID distribution status
In Commercial Distribution

Similar devices in this category

Other devices filed under Bipolar femoral head outer component, hemiarthroplasty.

Other devices from Medacta International SA

See all devices from Medacta International SA →

Properties

  • Supplied sterile
  • Single use
  • Implantable
  • Prescription use
  • Lot / batch number
  • Expiration date
Other properties (9, all answered No)